{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:53:01Z","timestamp":1776919981942,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00198-017-4132-y","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T17:19:52Z","timestamp":1498756792000},"page":"2921-2928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users"],"prefix":"10.1007","volume":"28","author":[{"given":"P. A.","family":"Eiken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"4132_CR1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/jbmr.2918","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:1910","journal-title":"J Bone Miner Res"},{"key":"4132_CR2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ et al (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M et al (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"4132_CR6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"4132_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","volume":"20","author":"AA Khan","year":"2017","unstructured":"Khan AA, Morrison A, Kendler DL et al (2017) Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ. J Clin Densitom 20:8\u201324","journal-title":"J Clin Densitom"},{"key":"4132_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O'Ryan FS, Gordon NP et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","volume":"117","author":"M Schiodt","year":"2014","unstructured":"Schiodt M, Reibel J, Oturai P et al (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117:204\u2013213","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4132_CR11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347","journal-title":"Ann Oncol"},{"key":"4132_CR12","unstructured":"Population and elections. \nhttp:\/\/www.dst.dk\/Site\/Dst\/Udgivelser\/GetPubFile.aspx?id=22256&sid=pop\n\n. Accessed March 8, 2017."},{"key":"4132_CR13","doi-asserted-by":"crossref","first-page":"i3365","DOI":"10.1136\/bmj.i3365","volume":"353","author":"B Abrahamsen","year":"2016","unstructured":"Abrahamsen B, Eiken P, Prieto-Alhambra D et al (2016) Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ 353:i3365","journal-title":"BMJ"},{"key":"4132_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CLEP.S71796","volume":"7","author":"M Schiodt","year":"2015","unstructured":"Schiodt M, Larsson Wexell C, Herlofson BB et al (2015) Existing data sources for clinical epidemiology: Scandinavian cohort for osteonecrosis of the jaw\u2014work in progress and challenges. Clin Epidemiol 7:107\u2013116","journal-title":"Clin Epidemiol"},{"key":"4132_CR15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pds.3786","volume":"24","author":"V Ehrenstein","year":"2015","unstructured":"Ehrenstein V, Gammelager H, Schiodt M et al (2015) Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients. Pharmacoepidemiol Drug Saf 24:693\u2013700","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4132_CR16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ et al (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"},{"key":"4132_CR17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","volume":"15","author":"JJ Caro","year":"2004","unstructured":"Caro JJ, Ishak KJ, Huybrechts KF et al (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15:1003\u20131008","journal-title":"Osteoporos Int"},{"key":"4132_CR18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139","journal-title":"Med Care"},{"key":"4132_CR19","unstructured":"http:\/\/laegemiddelstyrelsen.dk\/da\/nyheder\/2012\/aendrede-kriterier-for-enkelttilskud-til-oevrige-osteoporosemidler-end-alendronat\/~\/media\/072DF0C8F48540F2964EAB109CB2D1D6.ashx\n\n. Accessed March 8, 2017."},{"key":"4132_CR20","first-page":"70","volume":"35","author":"P Pablo de","year":"2008","unstructured":"de Pablo P, Dietrich T, McAlindon TE (2008) Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 35:70\u201376","journal-title":"J Rheumatol"},{"key":"4132_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","volume":"30","author":"N Malden","year":"2012","unstructured":"Malden N, Lopes V (2012) An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence. J Bone Miner Metab 30:171\u2013182","journal-title":"J Bone Miner Metab"},{"key":"4132_CR22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00198-013-2575-3","volume":"25","author":"SH Lee","year":"2014","unstructured":"Lee SH, Chang SS, Lee M et al (2014) Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis. Osteoporos Int 25:1131\u20131139","journal-title":"Osteoporos Int"},{"key":"4132_CR23","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE et al (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296:2927\u20132938","journal-title":"JAMA"},{"key":"4132_CR24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","volume":"25","author":"AV Schwartz","year":"2010","unstructured":"Schwartz AV, Bauer DC, Cummings SR et al (2010) Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res 25:976\u2013982","journal-title":"J Bone Miner Res"},{"key":"4132_CR25","unstructured":"Statement by Merck & Company. Incorporated: Regarding Fosamax (alendronate sodium) and rare cases of osteonecrosis of the jaw. Product News. 9 March 2010. Available from: \nhttp:\/\/www.mercknewsroom.com\/news\/statement-merck-regarding-fosamax-alendronate-sodium-and-rare-cases-osteonecrosis-jaw\n\n. Accessed December 19, 2016."},{"key":"4132_CR26","unstructured":"Fung P, Bedogni G, Bedogni A, et al. Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study. Oral Dis 2016."},{"key":"4132_CR27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tripleo.2005.04.010","volume":"100","author":"E Dervis","year":"2005","unstructured":"Dervis E (2005) Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:349\u2013356","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"4132_CR28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.joms.2011.02.093","volume":"70","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Schwartz K, Rejnmark L et al (2012) Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. J Oral Maxillofac Surg 70:821\u2013829","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","volume":"12","author":"J Yamashita","year":"2012","unstructured":"Yamashita J, McCauley LK (2012) Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract 12:233\u2013247","journal-title":"J Evid Based Dent Pract"},{"key":"4132_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","volume":"27","author":"TB Dodson","year":"2015","unstructured":"Dodson TB (2015) The frequency of medication-related osteonecrosis of the jaw and its associated risk factors. Oral Maxillofac Surg Clin North Am 27:509\u2013516","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"4132_CR31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","volume":"41","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T et al (2012) Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg 41:1397\u20131403","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4132_CR32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","volume":"71","author":"C Tsao","year":"2013","unstructured":"Tsao C, Darby I, Ebeling PR et al (2013) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg 71:1360\u20131366","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR33","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.joms.2011.08.033","volume":"70","author":"FS O'Ryan","year":"2012","unstructured":"O'Ryan FS, Lo JC (2012) Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg 70:1844\u20131853","journal-title":"J Oral Maxillofac Surg"},{"key":"4132_CR34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oooo.2014.12.024","volume":"119","author":"PM Yazdi","year":"2015","unstructured":"Yazdi PM, Schiodt M (2015) Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ cohort. Oral Surg Oral Med Oral Pathol Oral Radiol 119:416\u2013422","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4132_CR35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto S, Schreyer C, Hafner S et al (2012) Bisphosphonate-related osteonecrosis of the jaws\u2014characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40:303\u2013309","journal-title":"J Craniomaxillofac Surg"},{"key":"4132_CR36","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1038\/sj.bdj.2013.327","volume":"214","author":"T Taylor","year":"2013","unstructured":"Taylor T, Bryant C, Popat S (2013) A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King\u2019s College Hospital. Br Dent J 214:E18","journal-title":"Br Dent J"},{"key":"4132_CR37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/CLEP.S45226","volume":"5","author":"H Gammelager","year":"2013","unstructured":"Gammelager H, Svaerke C, Noerholt SE et al (2013) Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients. Clin Epidemiol 5:263\u2013267","journal-title":"Clin Epidemiol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4132-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T15:29:03Z","timestamp":1506958143000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["4132"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4132-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}